Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Cash Inflow / Outflow ₹2,169 Cr₹-1,021 Cr₹223 Cr₹-1,164 Cr₹2,563 Cr

What is the latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA ?

The latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA is ₹2,169 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹2,169 Cr
Mar2024₹-1,021 Cr
Mar2023₹223 Cr
Mar2022₹-1,164 Cr
Mar2021₹2,563 Cr

How is Net Cash Inflow / Outflow of AUROBINDO PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹2,169 Cr
Positive
Mar2024 ₹-1,021 Cr
Negative
Mar2023 ₹223 Cr
Positive
Mar2022 ₹-1,164 Cr
Negative
Mar2021 ₹2,563 Cr -

Compare Net Cash Inflow / Outflow of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹89,077.7 Cr -1.1% 11% 35.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,870.0 Cr 0.8% 8.3% 17.1% Stock Analytics
DIVIS LABORATORIES ₹194,316.0 Cr 7.1% 9% 4.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹169,316.0 Cr 2% 12.1% 49.6% Stock Analytics
CIPLA ₹115,477.0 Cr -0.7% 4.1% -3.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,156.0 Cr -1.7% -4.2% -3.1% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-1.1%

11%

35.6%

SENSEX

0.6%

1.2%

-7.8%


You may also like the below Video Courses